ClinConnect ClinConnect Logo
Search / Trial NCT05049655

Multi-Center Clinical Database of Infants for the Investigation of Early Nutrition Biomarkers

Launched by BYHEART · Sep 9, 2021

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

The first Cohort (Cohort 1) goals of the registry include: to compile a clinical database of children who were fed in SS-101-18 by breastfeeding, commercial formula, or ByHeart formula; to investigate any difference in demographics, growth, development, medical diagnoses, and outcomes between the feeding groups, and in particular to compare ByHeart formula-fed infants against commercial formula-fed infants, and referenced against breastfed infants.

The second Cohort (Cohort 2) goals of the registry include: to compile a clinical database of children who were fed by breastfeeding or commerc...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria Cohort 1:
  • Active participation in SS-101-18 through Visit 9
  • Provision of signed and dated informed consent form (ICF) by parent or legally authorized representative (LAR)
  • Stated willingness to comply with all study procedures by parent or LAR.
  • Exclusion Criteria Cohort 1:
  • Did not participate in SS-101-18
  • Participated in SS-101-18 that withdrew from the study for any reason prior to Visit 9
  • Anything that in the opinion of the Investigator is likely to interfere with participation in the registry.
  • Inclusion Criteria Cohort 2:
  • Be less than 120 days old at the time of enrollment
  • Provision of signed and dated informed consent form (ICF) by parent or legally authorized representative (LAR)
  • Stated willingness to comply with all study procedures by parent or LAR.
  • Exclusion Criteria Cohort 2:
  • Participation in SS-101-18
  • Anything that, in the opinion of the Investigator, is likely to interfere with participation in the registry.
  • In the opinion of the investigator, has a diagnosed medical condition or genetic abnormality known to impact growth or development.

About Byheart

ByHeart is a pioneering nutrition company dedicated to transforming infant formula with a focus on quality, safety, and innovation. Committed to advancing infant health, ByHeart employs rigorous scientific research and clinical trials to develop products that meet the highest standards of nutritional excellence. With a mission to provide parents with trusted, evidence-based options, ByHeart leverages cutting-edge technology and a team of experts to ensure that their formulas are not only effective but also aligned with the latest advancements in pediatric nutrition. Through its commitment to transparency and consumer education, ByHeart aims to empower families in making informed choices for their children's health and well-being.

Locations

Kingsport, Tennessee, United States

Jonesboro, Arkansas, United States

Birmingham, Alabama, United States

Tampa, Florida, United States

Charleston, South Carolina, United States

Summerville, South Carolina, United States

Tucson, Arizona, United States

Cincinnati, Ohio, United States

Birmingham, Alabama, United States

Tucson, Arizona, United States

Jonesboro, Arkansas, United States

Tampa, Florida, United States

Cincinnati, Ohio, United States

Charleston, South Carolina, United States

Summerville, South Carolina, United States

Kingsport, Tennessee, United States

Idaho Falls, Idaho, United States

Layton, Utah, United States

Tuscan, Arizona, United States

Patients applied

0 patients applied

Trial Officials

Devon Kuehn, M.D.

Study Director

ByHeart

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials